US2014220109A1PendingUtilityA1
Novel cochleate formulations
Est. expiryJan 22, 2019(expired)· nominal 20-yr term from priority
A61P 9/10A61P 37/06A61P 25/20A61P 31/04A61P 31/12A61P 29/00A61P 35/00A61P 31/10A61P 23/00A61K 9/1274A61K 31/11A61K 31/496Y10T428/2984A61K 31/472A61K 38/13A61K 31/07A61K 31/20A61K 31/713A61K 31/7048A61K 36/54A61K 31/704Y10S436/829
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process for producing a small-sized, lipid-based cochleates. Cochleates are derived from liposomes which are suspended in an aqueous two-phase polymer solution, enabling the differential partitioning of polar molecule based-structures by phase separation. The liposome-containing two-phase polymer solution, treated with positively charged molecules such as Ca 2+ or Zn 2+ , forms a cochleate precipitate of a particle size less than one micron. The process may be used to produce cochleates containing biologically relevant molecules.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A cochleate composition comprising a population of cochleates, wherein the cochleates comprise:
a negatively charged first lipid; a divalent cation or higher valency cation and an additional biologically relevant molecule,
wherein the mean particle size of the cochleates is less than one micron.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.